Ignite Creation Date:
2025-12-25 @ 4:35 AM
Ignite Modification Date:
2025-12-26 @ 3:37 AM
Study NCT ID:
NCT06165718
Status:
RECRUITING
Last Update Posted:
2023-12-15
First Post:
2023-12-04
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study for the Clinical Roadmap and Prognosis of Pulmonary Artery Sarcoma.
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'COHORT'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 120}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'RECRUITING', 'startDateStruct': {'date': '2022-12-31', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2023-12', 'completionDateStruct': {'date': '2025-06-30', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2023-12-11', 'studyFirstSubmitDate': '2023-12-04', 'studyFirstSubmitQcDate': '2023-12-04', 'lastUpdatePostDateStruct': {'date': '2023-12-15', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2023-12-11', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2024-12-31', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Progression-free survival', 'timeFrame': '36 months', 'description': 'Time to death or disease progression'}], 'secondaryOutcomes': [{'measure': 'Overall survival', 'timeFrame': '36 months', 'description': 'Time to death'}, {'measure': 'Postoperative survival', 'timeFrame': '36 months', 'description': 'Time from surgery to death'}]}, 'oversightModule': {'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Pulmonary Artery Sarcoma']}, 'descriptionModule': {'briefSummary': 'This is an observational study in which patients with pulmonary artery sarcoma were followed up for at least 36 months and survival was investigated.', 'detailedDescription': 'This is an observational study covering mainland China, and patients with pulmonary artery sarcoma were followed up for at least 36 months and survival was investigated.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Pulmonary artery sarcoma patients expected to complete follow-up', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Computed tomography pulmonary angiography indicated that there were intraluminal defects\n* Malignant histopathology was sarcoma\n* Informed consent form was signed\n\nExclusion Criteria:\n\n* Life expectancy was less than 3 months due to diseases other than pulmonary artery sarcoma\n* Expected inability to complete follow-up'}, 'identificationModule': {'nctId': 'NCT06165718', 'briefTitle': 'Study for the Clinical Roadmap and Prognosis of Pulmonary Artery Sarcoma.', 'organization': {'class': 'OTHER', 'fullName': 'China-Japan Friendship Hospital'}, 'officialTitle': 'A Multicenter, Observational Study for the Clinical Roadmap and Prognosis of Pulmonary Artery Sarcoma.', 'orgStudyIdInfo': {'id': 'Roadmap for PAS-2022'}}, 'contactsLocationsModule': {'locations': [{'zip': '100029', 'city': 'Beijing', 'state': 'Beijing Municipality', 'status': 'RECRUITING', 'country': 'China', 'contacts': [{'name': 'Wanmu Xie', 'role': 'CONTACT', 'email': 'xiewanmu@126.com', 'phone': '+86 15611734410'}, {'name': 'Wanmu Xie', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'China-Japan Friendship Hospital', 'geoPoint': {'lat': 39.9075, 'lon': 116.39723}}], 'centralContacts': [{'name': 'Wanmu Xie', 'role': 'CONTACT', 'email': 'xiewanmu@126.com', 'phone': '+86 15611734410'}], 'overallOfficials': [{'name': 'Wanmu Xie', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'China-Japan Friendship Hospital'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'China-Japan Friendship Hospital', 'class': 'OTHER'}, 'collaborators': [{'name': 'The First Affiliated Hospital of Guangzhou Medical University', 'class': 'OTHER'}, {'name': 'Beijing Chao Yang Hospital', 'class': 'OTHER'}, {'name': 'Shanghai Pulmonary Hospital, Shanghai, China', 'class': 'OTHER'}, {'name': 'Sir Run Run Shaw Hospital', 'class': 'OTHER'}, {'name': 'Beijing Anzhen Hospital', 'class': 'OTHER'}], 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Professor', 'investigatorFullName': 'Wanmu Xie', 'investigatorAffiliation': 'China-Japan Friendship Hospital'}}}}